SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001072613-20-000097
Filing Date
2020-02-13
Accepted
2020-02-13 16:51:01
Documents
1
Group Members
ARCH VENTURE FUND VIII OVERAGE, L.P.ARCH VENTURE PARTNERS VII, L.P.ARCH VENTURE PARTNERS VII, LLCARCH VENTURE PARTNERS VIII, LLCCLINTON BYBEEKEITH CRANDELLROBERT NELSEN

Document Format Files

Seq Description Document Type Size
1 ARCH VENTURE FUND VII, L.P. - UNITY BIOTECHNOLOGY, INC. -- SCHEDULE 13G/A(#1) archvii-unity_13g18372.htm SC 13G/A 320094
  Complete submission text file 0001072613-20-000097.txt   322110
Mailing Address 8755 W HIGGINS SUITE 1025 Chicago IL 60631
Business Address 8755 W HIGGINS SUITE 1025 Chicago IL 60631 773-380-6600
ARCH Venture Fund VII, L.P. (Filed by) CIK: 0001402439 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Subject) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90777 | Film No.: 20611566
SIC: 2834 Pharmaceutical Preparations